Pathology

Business

Disease

Counterfeit

Population

Coronavirus disease 2019 (COVID-19)

Infectious disease (medical specialty)

Pandemic

Political science

Intensive care medicine

Immunology

Malaria

Traditional medicine

Medicine

Environmental health

The Lancet Global Health

Emergency efforts are underway to find optimum medical products to prevent infection and diagnose and treat patients during the coronavirus disease 2019 (COVID-19) pandemic. Production and supply chains for COVID-19 candidate drugs (such as chloroquine and hydroxychloroquine), and for many other essential medical products, are being impaired by this crisis.1 Supply chains for vital drugs for other diseases (such as systemic lupus erythematosus) are being disrupted because they are being repurposed to use against COVID-19, without adequate supporting evidence.

COVID-19 and risks to the supply and quality of tests, drugs, and vaccines